Replies to post #18153 on Biotech Values

[DewDiligence]

>Do you think NPSP can take a pie of the Baby boomers osteoporosis market?<

I assume you meant a slice of the pie rather than the whole pie. If the modest sales of LLY’s Forteo are a guide, I would not expect NPSP’s Preos to end up in the same league with the likes of AMGN’s candidate.

Here’s a background piece on the osteoporosis arena: #msg-6341196. Regards, Dew